Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Alpine Immune Sciences 13G Filing From Great Point Partners, LLC Shows 7.85% Stake

Alpine Immune Sciences 13G Filing From Great Point Partners, LLC Shows 7.85% Stake

– 13G Filing

byBenzinga Newsdesk

September 30, 2022

1 minute read

– 13G Filing

Cathie Wood’s ARK Invest And 21Shares File For Bitcoin, Ethereum Futures ETFs

By Murtuza Merchant

August 25, 10:40 AM

ARK Invest, led by Cathie Wood, in collaboration with 21Shares, has submitted applications for two futures exchange-traded fund (ETF) products centered on Ether (CRYP

BLK

Keefe, Bruyette & Woods Maintains Outperform on Cadence Bank, Lowers Price Target to $32

By Benzinga Newsdesk

February 2, 11:16 AM

Keefe, Bruyette & Woods analyst Catherine Mealor maintains Cadence Bank (NYSE:CADE) with a Outperform and lowers the price target from $35 to $32.

CADE

ECB’s De Cos Says ECB Will Continue Raising Interest Rates “Significantly” At Future Meetings At A Sustained Pace

By Benzinga Newsdesk

January 11, 4:01 PM

- Reuters

VGK

News

A Look Into Financial Services Sector Value Stocks

By Benzinga Insights

October 5, 10:49 AM

What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices…

AMAL

Alpine Immune Sciences 13G Filing From Great Point Partners, LLC Shows 7.85% Stake

Related Posts

Cathie Wood’s ARK Invest And 21Shares File For Bitcoin, Ethereum Futures ETFs

Keefe, Bruyette & Woods Maintains Outperform on Cadence Bank, Lowers Price Target to $32

ECB’s De Cos Says ECB Will Continue Raising Interest Rates “Significantly” At Future Meetings At A Sustained Pace

A Look Into Financial Services Sector Value Stocks